Patents/Assignees

GENECRAFT Inc.

5 patents in portfolio

US12414980utility2025
Pharmaceutical Composition Comprising RUNX3 Protein and CDK4 Inhibitor or Mtor Inhibitor Cotreatment for Prevention or Treatment of Cancer
0 cites
US11993783utility2024
Nucleic Acid Molecule Comprising Asymmetrically Modified ITR for Improving Expression Rate of Inserted Gene, and Use Thereof
0 cites
US11931401utility2024
Runx3 Modified Protein for Prevention or Treatment of Cancer
0 cites
US11891617utility2024
Modified Complex Platform of Adeno-associated Virus with Improved Rate of Expression of Loaded Genes and Reduced Genotoxicity
0 cites
US11767541utility2023
Adeno-associated Virus Complex with Improved Expression of RUNX3 Gene and Uses for Preventing or Treating KRAS Mutated Lung Cancer
0 cites